益盛药业品牌怎么样 申请店铺

从1997年创业至今，十几年的默默耕耘，十几年的风雨兼程，益盛药业从大山深处的一家小型民营企业，成长为中国A股市场的上市公司，先后被认定为国家重点高新技术企业、国家生物医药产业基地骨干企业、国家农业产业化龙头企业；公司获得中华总工会颁发的“全国五一劳动奖状”、被国家外专局指定为“国家非林地人参种植引智示范单位”；2011年，公司又被吉林省政府列入首批人参药食同源试点企业。

诞生于大山深处的益盛药业，以“传承中华文明，服务人类健康”为企业宗旨，秉持“关爱众生，诚信笃实，以人为本，创新为先”的核心理念，确立了“依托长白山优质资源，依靠现代科学技术，打造完整人参产业链”的发展战略，并稳步完成了益盛药业、益盛参业、益盛永泰蜂业三大品牌的战略布局，这三大品牌统一在战略总目标下，构成这一目标的三大支撑。

在药业方面，公司首先集中全部力量，实现在人参、西洋参基础研究上的重大突破，然后将科研成果全面转化为产品优势，再将产品优势快速转化为市场优势。从1997年开始，公司便与吉林大学、天津中医药大学、沈阳医药大学、清华大学、北京大学等全国知名高校、科研机构建立起紧密的技术协作体，从人参根到人参茎叶、人参花、人参果，都开发出了国药准字号的产品，成为医药行业内，首家实现人参全株开发的企业。公司对西洋参的研究也取得丰硕成果，获得两项发明专利，开发出国家五类（原二类）新药“心悦胶囊”，该产品的研发被列为国家十五、十一五科技支撑计划重大项目。

这些以人参、西洋参为主料的产品，在临床应用上，其功效明显优于竞争品种。产品疗效上的优势，迅速转化为市场上的竞争优势。公司在全国建立了30个省级销售部，200多个市级销售部，产品覆盖全国30个省市的2700多家县（区）级以上医疗单位，15000多家乡镇卫生院和卫生所。公司的业绩在14年的时间里，增长了15倍，利税连年增长，对本地区经济社会的发展做出了应有的贡献。

截止2011年底，公司已有11个剂型通过了GMP认证，拥有国药准字号品种116个，其中52个品种被列入国家医保目录，13个品种被列入《国家基本药物目录》，拥有国家中药保护品种2个，独家品种6个。药品治疗范围以心脑血管疾病为主，涵盖了呼吸系统、消化系统、内分泌系统、泌尿系统以及肿瘤、儿科疾病等。公司运用多项核心技术，确保产品品质，赢得了广大医生和患者的高度信赖。

在参业方面，由药业奠定的坚实基础，使公司具备了向人参上游产业进军的条件。自2006年起，公司会同吉林农业大学，按照GAP标准，以机械化、标准化、规范化、集约化的方式，在国内首开“非林地人参种植”的先河。同时，开发出人参专用有机肥，填补了我国没有人参专用有机肥的空白，建成了年生产能力10000吨的有机肥厂和年生产能力3000吨的微生物液肥车间。

在蜂业方面，公司于2011年10月投资控股了集安市永泰蜂业有限责任公司。蜂蜜是人参功能食品加工的重要原料，长白山是中国北方最重要的天然蜜源基地，也是联合国教科文组织指定的“世界自然保留地”，在没有任何污染的原生态环境里，生长着我国北方特有的树种---椴树，蜂蜜中的上品椴树蜜，主要就出产自这一地区。集安永泰蜂业是长白山区最有影响力的蜂制品企业之一，在蜂农中拥有较高威信和良好信誉。控股永泰蜂业，意味着公司实现了对长白山南麓天然蜂蜜资源的相对垄断，既从根本上保障了人参深加工所需的重要原料，又新增了一项独立产业。目前，益盛永泰蜂业已拥有蜂蜜、蜂胶、蜂王浆、蜂花粉4大系列30个品种，正着力开发参、蜜结合的新型功能食品，努力使人参产业链得到有效的延伸。

Since its establishment in 1997, Yisheng Pharmaceutical Co., Ltd. has grown from a small private enterprise deep in the mountains to a listed company in China's A-share market. It has been recognized as a national key high-tech enterprise, a backbone enterprise in the national biomedical industry base, and a national leading enterprise in agricultural industrialization. The company has been awarded by the China Federation of trade unions The "National May 1st Labor Award" was designated as the "national non forest land ginseng planting and intelligence introduction demonstration unit" by the State Administration of foreign affairs; in 2011, the company was listed in the first batch of ginseng drug and food homologous pilot enterprises by the Jilin provincial government. Yisheng pharmaceutical industry, which was born in the depth of the mountain, takes "inheriting Chinese civilization and serving human health" as the enterprise tenet, adheres to the core concept of "caring for all living beings, being honest, practical, people-oriented and innovation first", establishes the development strategy of "relying on the high-quality resources of Changbai Mountain and relying on modern science and technology to build a complete ginseng industry chain", and steadily completes Yisheng pharmaceutical industry and Yisheng The strategic layout of the three brands of Shenye and yishengyongtai bee industry, which are unified under the overall strategic goal, constitutes the three supports of this goal. In the pharmaceutical industry, the company first concentrated all its efforts to achieve a major breakthrough in the basic research of ginseng and American ginseng, then comprehensively transformed the scientific research results into product advantages, and then quickly transformed the product advantages into market advantages. Since 1997, the company has established close technical cooperation with Jilin University, Tianjin University of traditional Chinese medicine, Shenyang University of medicine, Tsinghua University, Peking University and other national famous universities and scientific research institutions. From ginseng root to ginseng stem and leaf, ginseng flower and ginseng fruit, the company has developed the products with the national medicine license, becoming the first enterprise in the pharmaceutical industry to realize the full plant development of ginseng 。 The company has also made fruitful achievements in the research of American ginseng, obtained two invention patents, and developed five kinds of new drugs "Xinyue capsule". The research and development of this product is listed as a major project in the national science and technology support plan of the 15th and 11th five year plan. These products with ginseng and American ginseng as the main materials are superior to the competitive varieties in clinical application. The advantages of product efficacy are rapidly transformed into competitive advantages in the market. The company has established 30 provincial sales departments, more than 200 municipal sales departments, and its products cover more than 2700 county (District) level and above medical units in 30 provinces and cities, and more than 15000 township hospitals and health centers. In the past 14 years, the company's performance has increased 15 times, and its profits and taxes have increased year by year, making due contributions to the economic and social development of the region. By the end of 2011, the company has passed GMP certification in 11 dosage forms, with 116 varieties under the state drug license, 52 of which have been listed in the national medical insurance catalog, 13 of which have been listed in the national basic drug catalog, 2 of which are under the state protection of traditional Chinese Medicine, and 6 of which are exclusive. The medicine treatment scope mainly includes cardiovascular and cerebrovascular diseases, including respiratory system, digestive system, endocrine system, urinary system, tumor, pediatric diseases, etc. The company uses a number of core technologies to ensure product quality and win the high trust of doctors and patients. In terms of participation, the solid foundation laid by the pharmaceutical industry enables the company to have the conditions to march into the upstream industry of participation. Since 2006, the company, together with Jilin Agricultural University and in accordance with gap standards, has been the first to "non forest ginseng planting" in China in the way of mechanization, standardization, standardization and intensification. At the same time, the development of ginseng specific organic fertilizer has filled in the blank of no ginseng specific organic fertilizer in China, and has built an organic fertilizer plant with an annual production capacity of 10000 tons and a microbial liquid fertilizer workshop with an annual production capacity of 3000 tons. In terms of bee industry, the company invested and controlled Ji'an Yongtai Bee Industry Co., Ltd. in October 2011. Honey is an important raw material for processing ginseng functional food. Changbai Mountain is the most important natural honey source base in northern China, and also the "World Natural Reserve" designated by UNESCO. In the original ecological environment without any pollution, there is a unique tree species in northern China - Tilia trees. The top grade Tilia honey in honey is mainly produced in this area. Ji'an Yongtai bee industry is one of the most influential bee products enterprises in Changbai Mountain area. It has high prestige and good reputation among bee farmers. Holding Yongtai bee industry means that the company has achieved a relative monopoly on the natural honey resources at the south foot of Changbai Mountain, which not only fundamentally guarantees the important raw materials needed for the deep processing of ginseng, but also adds an independent industry. At present, Yisheng Yongtai bee industry has 4 series and 30 varieties of honey, propolis, royal jelly and bee pollen. It is striving to develop new functional food combining ginseng and honey, and strive to effectively extend the ginseng industry chain.

本文链接： https://brand.waitui.com/6d0c156ca.html 联系电话：010-84966663